13F

Stock

Acrivon Therapeutics, Inc.

ACRV · held by 2 managers

Reported value

$204.3K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$28.8K

Price effect on 1 books still in the name

Largest holder

$127.8K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC22K$127.8K−$28.8KCut−$24.7K
Marex Group plc13.2K$76.5KNew

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.